The RIO study will see whether immune-based therapy (called bNAbs) can be used to manage HIV.
Two long-acting treatments will be given by infusion and be used instead of oral meds.
The study will be open to people who started HIV treatment soon after they became HIV positive.
More information will be added to this page after the study is fully approved.
Although enrolment was due to start in Spring 2020, the study was delayed because of COVID-19.
The study is now planned to open in May 2021 when most potential participants are likely to have had access to COVID-19 vaccines.
This short video is about the RIO study.